Tag Archives: BPMC

Monday’s Midday Stock Update: Karyopharm Therapeutics (KPTI), Peabody Energy Comm (BTU), Arrowhead Research (ARWR), Blueprint Medicines (BPMC), Aerie Pharma (AERI)

So far Monday, December 2, NASDAQ is down -4.72% and the S&P is down -2.6%. Here are this morning’s most active stocks: Karyopharm Therapeutics (KPTI – Research Report), Peabody Energy Comm (BTU – Research Report), Arrowhead Research (ARWR – Research

Friday’s Midday Movers: Clovis Oncology (CLVS), TG Therapeutics (TGTX), Blueprint Medicines (BPMC), Arrowhead Research (ARWR), United States Steel (X)

So far Friday, November 29, NASDAQ is up 0.26% and the S&P is down -0.36%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Clovis Oncology (CLVS – Research Report), TG Therapeutics (TGTX –

Blueprint Medicines (BPMC) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $100.00. The company’s shares closed last Monday at $74.10. According to TipRanks.com, Fein is a 4-star analyst

Blueprint Medicines (BPMC) Received its Third Buy in a Row

After Morgan Stanley and JMP Securities gave Blueprint Medicines (NASDAQ: BPMC) a Buy rating last month, the company received another Buy, this time from Cowen & Co. Analyst Marc Frahm reiterated a Buy rating on Blueprint Medicines today. The company’s

Monday’s Midday Stock Update: La Jolla Pharma (LJPC), TG Therapeutics (TGTX), Blueprint Medicines (BPMC), Virnetx Holding Corp (VHC), Rite Aid Corp (RAD)

So far Monday, October 28, NASDAQ is up 2.59% and the S&P is up 0.48%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; La Jolla Pharma (LJPC – Research Report), TG Therapeutics (TGTX

Cowen & Co. Keeps Their Buy Rating on Blueprint Medicines (BPMC)

In a report released today, Marc Frahm from Cowen & Co. maintained a Buy rating on Blueprint Medicines (BPMC – Research Report). The company’s shares closed last Monday at $73.68. According to TipRanks.com, Frahm is currently ranked with no stars